Global Clinical Diagnostics Automation Market to Reach $10.5 Billion by 2017, According to a New Report by Global Industry Analysts, Inc.

San Jose, California (PRWEB) April 28, 2011

Clinical laboratories worldwide are increasingly eying automation as a key aspect to their future survival, as economic forces continue to intensify competition in the market. Presently, several market forces are acting in tandem that is threatening the sustenance of several players in the market. These include continued decline in reimbursement rates for laboratory tests, cost-cutting measures adopted by the managed care industry, and the general shift towards cutting healthcare costs. Such forces are creating relentless pressure on laboratories to increase cost-efficiency and productivity. An obvious way to achieve the same is to alter internal processes that could deliver increased productivity at lower budgets, an area where automation proves to be a major solution.

Although several options are available for enhancing laboratory efficiency, automation stands apart given its ability to bring in significant cost-savings into clinical laboratories. Over the recent years, the industry has observed a decline in expenses pertaining to clinical and biological diagnostics, despite a rise in sophistication of technologies employed and a wide range of parameters for detection. Apposite portfolio of automated systems in various laboratory settings can make them an ideal solution for enhancing robustness and efficiency. Going forwards, however, technologies should focus on ability of these systems to be used by any member of the staff in a laboratory rather than highly trained specialists. As the market further progresses and novel instruments with enhanced features surface, manufacturers are required to focus enhancing awareness of potential applications of such products to end users.

The US represents the single largest market for clinical diagnostics automation worldwide, as stated by the new market research report on Clinical Diagnostics Automation. Europe represents the second largest market for clinical diagnostics automation. However, market growth for clinical diagnostics automation is expected to mainly emanate from the Rest of the World market, which is forecast to grow at a compounded annual rate of more than 12% during the analysis period, driven primarily by the burgeoning population in Asia. The global market for clinical diagnostics automation is led by automated analyzers. Stand-alone automation represents the fastest growing segment in the global clinical diagnostics automation market, with a projected CAGR of 16.8% during the analysis period.

Total Lab Automation (TLA) is ideal for use in large hospitals with 550 beds or more, or with a substantially large outpatient numbers. Adoption of TLA remains confined to only a few large hospitals, serving a niche market. Despite being powerful and efficient, large-scale automation systems are laden with certain limitations such as inflexibility, complexity, huge time for implementation, and certain communication issues in addition to cost constraints. This resulted in a lower penetration of TLA in the market. Meanwhile, smaller laboratories have espoused modular work cell automation concept, which is relatively more ideal for their size and budget.

--------

For more details about this comprehensive market research report, please visit - www.strategyr.com/Clinical_Diagnostics_Automation_Market_Report.asp